Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi Centre, Double-Blind, Randomised, Placebo Controlled Prospective Study on the Safety and Efficacy of Aurograb in Patients With Severe, Deep-Seated Staphylococcal Infections Receiving Vancomycin

NCT00217841 is registered in ClinicalTrials.gov with NeuTec Pharma as lead sponsor.

NCT NCT00217841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00217841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi Centre, Double-Blind, Randomised, Placebo Controlled Prospective Study on the Safety and Efficacy of Aurograb in Patients With Severe, Deep-Seated Staphylococcal Infections Receiving Vancomycin
Lead sponsor
NeuTec Pharma
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2004
Completion date
March 31, 2006
Enrollment
180
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

staphylococcal infections